Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Antismoking centers in Milan's communal pharmacies: analysis of the 2010-2011 campaign.

Munarini E, Marabelli C, Marmotti A, Gardiner A, Invernizzi G, Mazza R, De Marco C, Pozzi P, Boffi R.

Tumori. 2013 Sep-Oct;99(5):578-82. doi: 10.1700/1377.15305.

2.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
3.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
4.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
5.

Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.

Annemans L, Nackaerts K, Bartsch P, Prignot J, Marbaix S.

Clin Drug Investig. 2009;29(10):655-65. doi: 10.2165/11317730-000000000-00000.

PMID:
19715382
6.

An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.

Etter JF, Schneider NG.

Nicotine Tob Res. 2013 Jan;15(1):59-68. doi: 10.1093/ntr/nts084.

PMID:
22529220
7.

Nocturnal sleep-disturbing nicotine craving and accomplishment with a smoking cessation program.

Riemerth A, Kunze U, Groman E.

Wien Med Wochenschr. 2009;159(1-2):47-52. doi: 10.1007/s10354-008-0640-x.

PMID:
19225735
8.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
9.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006103. doi: 10.1002/14651858.CD006103.pub3. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD006103.

PMID:
18646137
10.

A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.

Xenakis JG, Kinter ET, Ishak KJ, Ward AJ, Marton JP, Willke RJ, Davies S, Caro JJ.

Pharmacoeconomics. 2011 Jun;29(6):497-510. doi: 10.2165/11589230-000000000-00000.

PMID:
21452908
11.

Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.

Athanasakis K, Igoumenidis M, Karampli E, Vitsou E, Sykara G, Kyriopoulos J.

Clin Ther. 2012 Aug;34(8):1803-14. doi: 10.1016/j.clinthera.2012.07.002.

PMID:
22818870
12.

The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data.

Fagerström K, Russ C, Yu CR, Yunis C, Foulds J.

Nicotine Tob Res. 2012 Dec;14(12):1467-73. doi: 10.1093/ntr/nts018.

PMID:
22467778
13.
14.

Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies.

Saxon AJ, Baer JS, Davis TM, Sloan KL, Malte CA, Fitzgibbons K, Kivlahan DR.

Nicotine Tob Res. 2003 Aug;5(4):589-96.

PMID:
12959797
15.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
16.

Pharmacotherapy for smoking cessation: present and future.

Aubin HJ, Karila L, Reynaud M.

Curr Pharm Des. 2011;17(14):1343-50. Review.

PMID:
21524268
17.
18.

Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.

Jiménez Ruiz CA, Ramos Pinedo A, Cicero Guerrero A, Mayayo Ulibarri M, Cristobal Fernández M, Lopez Gonzalez G.

Nicotine Tob Res. 2012 Sep;14(9):1035-9. doi: 10.1093/ntr/nts001.

PMID:
22345320
19.

Smoking cessation intervention: an evidence-based approach.

Laniado-Laborín R.

Postgrad Med. 2010 Mar;122(2):74-82. doi: 10.3810/pgm.2010.03.2124. Review.

PMID:
20203458
20.

Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.

Hoogendoorn M, Welsing P, Rutten-van Mölken MP.

Curr Med Res Opin. 2008 Jan;24(1):51-61.

PMID:
18021492
Items per page

Supplemental Content

Support Center